Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Evolus Inc shares valued at $2,214,486 were sold by MOATAZEDI DAVID on Jun 06 ’24. At $12.59 per share, MOATAZEDI DAVID sold 175,940 shares. The insider’s holdings dropped to 533,349 shares worth approximately $8.45 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MOATAZEDI DAVID sold 155,278 shares, netting a total of over 2,006,456 in proceeds. Following the sale of shares at $12.92 each, the insider now holds 533,349 shares.
Before that, MOATAZEDI DAVID had sold 140,214 shares from its account. In a trade valued at $1,784,686, the insider traded Evolus Inc shares for $12.73 each. Upon closing the transaction, the insider’s holdings decreased to 140,214 shares, worth approximately $8.45 million.
As published in a research note from Barclays on January 29, 2024, Evolus Inc [EOLS] has been rated up from an Equal weight to an Overweight and the price target has been revised to $16 from $10. Analysts at Needham started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of May 12, 2022, Barclays has increased its “an Underweight” rating to a “an Equal weight” for EOLS. Earlier on January 20, 2022, Truist upgraded its rating. Their new recommendation was “a Buy” for EOLS stock which previously was a “a Hold”.
Analyzing EOLS Stock Performance
During the last five days, there has been a surge of approximately 1.15%. Over the course of the year, Evolus Inc shares have jumped approximately 50.43%. Shares of the company reached a 52-week high of $16.29 on 08/23/24 and a 52-week low of $9.80 on 01/03/24. A 50-day SMA is recorded $12.59, while a 200-day SMA reached $12.19. Nevertheless, trading volume fell to 0.57 million shares from 0.2 million shares the previous day.
Support And Resistance Levels for Evolus Inc (EOLS)
According to the 24-hour chart, there is a support level at 15.58, which, if violated, would cause prices to drop to 15.31. In the upper region, resistance lies at 16.01. The next price resistance is at 16.17. RSI (Relative Strength Index) is 75.96 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.18, which suggests the price will increase in the coming days. Percent R is at 12.86%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
